Adequate hematological, renal, metabolic and hepatic function within - days prior to randomization
Acceptable hematological function:
Patients with confirmed advanced hematological malignancies
Adequate cardiovascular, hematological, liver and renal function
Hematological function:
Acceptable liver function, serum creatinine and hematological status
Hematological values:
Adequate cardiac, hematological, liver and renal function
Adequate hematological function, defined as:
Demonstrate adequate hematological, renal, hepatic, and coagulation function;
Adequate hematological function
Adequate hematological, hepatic and renal function prior to first dose
Adequate hematological, hepatic and renal function
Hematological function:
Adequate hematological, renal, hepatic and coagulation function is required.
Patients with acute hematological malignancies
Adequate hematological, hepatic, and renal function:
Patients diagnosed with hematological malignancies.
Acceptable hematological status
Adequate hematological, liver and kidney function.
Adequate hematological, liver, and kidney function
Acceptable hematological status
Adequate hematological, renal, and liver function
Adequate hematological, liver, and renal function
Hematological malignancies
Adequate major organ function (normal or minimal alteration in liver, kidney, hematological, metabolic and cardiac function)
Hematological function, as follows, without transfusion support:
Adequate hematological, liver and kidney function.
Hematological:
Adequate hematological parameters, i.e:
Abnormal hematological, renal, or liver function
Inadequate hematological, liver, renal, cardiac function
Adequate hematological, hepatic and renal function as defined in the protocol
Adequate hematological and biological function
Adequate hematological, renal, metabolic and hepatic function
Adequate hematological function defined as:
Adequate hematological, hepatic and renal function as defined in the protocol
Adequate hematological, renal and hepatic function
Hematological
Adequate hematological, liver and kidney function.
Adequate hematological function, defined as:
Adequate hematological function, defined as:
Adequate hematological, liver, and renal function
Must have adequate hematological function
Acceptable hematological status, liver and renal function as defined in the protocol
Acceptable hematological status:
Adequate hematological, renal and liver function
Adequate hematological, hepatic, and renal function:
Adequate hematological, renal, and hepatic function
Adequate hematological, renal and liver function For solid tumors only:
Adequate hematological and biological function; LVEF ?%
Adequate hepatic, renal, cardiac and hematological function
Adequate hematological, renal, metabolic and hepatic function
Inadequate hematological, hepatic, or renal function
Adequate hematological function (as defined in the study protocol)
Adequate hematological function unless inadequate function is due to underlying disease
Adequate hematological and biological function
Hematological function, as follows:
Adequate hematological, renal and liver function
Adequate hematological function
Participants with adequate hematological, liver, and renal function
Adequate hematological, renal and hepatic function.
With a hematological malignancy
Diagnosed with any solid or hematological cancer
Adequate hematological, hepatic, renal and cardiac function
Hematological: Total absolute phagocyte count ?/?L
Adequate hematological, liver and kidney function.
Adequate hematological, renal, and hepatic function
